中国妇幼健康研究
中國婦幼健康研究
중국부유건강연구
CHINESE JOURNAL OF MATERNAL AND CHILD HEALTH RESEARCH
2013年
5期
750-752
,共3页
陈益明%王芳%顾琳媛%王洁%褚雪莲%胡彩霞
陳益明%王芳%顧琳媛%王潔%褚雪蓮%鬍綵霞
진익명%왕방%고림원%왕길%저설련%호채하
二联法%产前筛查%妊娠中期%唐氏综合征
二聯法%產前篩查%妊娠中期%唐氏綜閤徵
이련법%산전사사%임신중기%당씨종합정
alpha-fetoprotein and free β-human chorionic gonadotropin assays%prenatal screening%second trimester%Down’s syndrome ( DS)
目的:了解二联法血清学产前筛查技术在中孕期妇女中筛查唐氏综合征( DS)胎儿的应用情况及效果评估。方法采用时间分辨荧光免疫法对中孕期(妊娠15~20+6周)妇女进行二联法血清学产前筛查,筛查为高风险(≥1:270)的孕妇,采用羊膜腔穿刺、羊水细胞培养和染色体核型分析进行产前诊断,并对分娩的新生儿进行网络随访,对可疑DS的新生儿行外周血染色体核型分析诊断。结果筛查出DS高风险1803例,筛查阳性率为4.05%,阳性者经羊水染色体检查,确诊9例胎儿;在随访的34715例筛查为低风险孕妇中确诊新生儿DS 6例。共确诊15例DS患儿,产前筛查检出率为60.00%(9/15),假阳性率为4.02%(1794/44551),假阴性检出率0.17‰(6/34715)。血清学筛查结果为高风险者,其检出DS儿的机率高于低风险者,两者差异有统计学意义(χ2=102.908,P<0.001)。结论中孕期妇女二联法血清学产前筛查技术是DS产前筛查异常胎儿的有效指标,但在随访过程中应注意筛查结果为假阴性或假阳性的解释工作。
目的:瞭解二聯法血清學產前篩查技術在中孕期婦女中篩查唐氏綜閤徵( DS)胎兒的應用情況及效果評估。方法採用時間分辨熒光免疫法對中孕期(妊娠15~20+6週)婦女進行二聯法血清學產前篩查,篩查為高風險(≥1:270)的孕婦,採用羊膜腔穿刺、羊水細胞培養和染色體覈型分析進行產前診斷,併對分娩的新生兒進行網絡隨訪,對可疑DS的新生兒行外週血染色體覈型分析診斷。結果篩查齣DS高風險1803例,篩查暘性率為4.05%,暘性者經羊水染色體檢查,確診9例胎兒;在隨訪的34715例篩查為低風險孕婦中確診新生兒DS 6例。共確診15例DS患兒,產前篩查檢齣率為60.00%(9/15),假暘性率為4.02%(1794/44551),假陰性檢齣率0.17‰(6/34715)。血清學篩查結果為高風險者,其檢齣DS兒的機率高于低風險者,兩者差異有統計學意義(χ2=102.908,P<0.001)。結論中孕期婦女二聯法血清學產前篩查技術是DS產前篩查異常胎兒的有效指標,但在隨訪過程中應註意篩查結果為假陰性或假暘性的解釋工作。
목적:료해이련법혈청학산전사사기술재중잉기부녀중사사당씨종합정( DS)태인적응용정황급효과평고。방법채용시간분변형광면역법대중잉기(임신15~20+6주)부녀진행이련법혈청학산전사사,사사위고풍험(≥1:270)적잉부,채용양막강천자、양수세포배양화염색체핵형분석진행산전진단,병대분면적신생인진행망락수방,대가의DS적신생인행외주혈염색체핵형분석진단。결과사사출DS고풍험1803례,사사양성솔위4.05%,양성자경양수염색체검사,학진9례태인;재수방적34715례사사위저풍험잉부중학진신생인DS 6례。공학진15례DS환인,산전사사검출솔위60.00%(9/15),가양성솔위4.02%(1794/44551),가음성검출솔0.17‰(6/34715)。혈청학사사결과위고풍험자,기검출DS인적궤솔고우저풍험자,량자차이유통계학의의(χ2=102.908,P<0.001)。결론중잉기부녀이련법혈청학산전사사기술시DS산전사사이상태인적유효지표,단재수방과정중응주의사사결과위가음성혹가양성적해석공작。
Objective To study the application and evaluate the efficacy of combined measurement of alpha -fetoprotein ( AFP) and freeβ-human chorionic gonadotropin (β-hCG) for screening Down’s syndrome (DS) fetuses in mid-term pregnant women.Methods Combined measurement of serum AFP and free β-hCG was used to screen second trimester pregnant women ( at 15-20 +6 gestational weeks ) by the time resolved fluroimmunoassay (TRFIA).The high risk pregnant women (≥1:270) underwent prenatal diagnosis by amniocentesis , cell culture and chromosome analysis .The newborns of them were followed up by network , and suspected newborns underwent peripheral blood chromosome analysis .Results Totally 1 803 of 44 566 pregnant women were diagnosed as high-risk of DS by prenatal screening , with the positive rate of 4.05%, in which 9 cases were diagnosed as DS by amniotic fluid chromosome examination .Six cases of DS fetuses were diagnosed among 34 715 followed-up low-risk pregnant women .There were 15 cases of DS fetuses in total .The detection rate of prenatal screening was 60.00%(9/15), the false positive rate and false negative rate was 4.02% (1 794/44 551) and 0.17‰ (6/34 715) respectively.High-risk women screened by serologic examination had more possibilities receiving DS than the low-risk ones, and there was significant difference between them (χ2 =102.908,P<0.001).Conclusion Combined measurement of AFP and free β-hCG is an effective indicator for screening DS in second trimester pregnant women .However , the explanation must be carefully carried out on the results being false positive or false negative during follow-up.